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S70.8% (p¼0.46). Coronary perforations (10.5 vs 3.0%, p<0.01) and need for pericardial
drainage (3.6 vs 1.0%, p¼0.02) were more frequent among retrograde compared to
antegrade approach. However, need for emergency cardiac surgery were similar (0 vs
0.9%,p¼0.57).RetrogradeCTOPCIwas relatedwith longer procedure time (149.758.6
vs 80.740.2 min. p<0.01), ﬂuoroscopy time (75.839.1 vs 42.599.8 min. p<0.01)
and higher contrast dose (385180 vs 257158ml, p<0.01). The incidence of in-hospital
non Q-wave myocardial infarction (0.7 vs 0.1%, p¼0.20) and death were similar (0.7 vs
1.1%, p¼0.66). The 3-year cumulative incidence ofmyocardial infarction (2.6% vs 1.3%,
p¼0.81) and cardiac death (4.8% vs 4.7%, p¼0.83) were similar between retrograde and
antegrade approach. Among patients with successful CTO PCI, the 3-year cumulative
target lesion revascularization (TLR) rate was signiﬁcantly higher in retrograde approach
compared with antegrade (12.6% vs 6.9%, p¼0.045).
Conclusions: Higher incidences of coronary perforation and pericardial drainage, but
no emergency cardiac surgery were observed after retrograde CTO PCI. Although
long-term TLR rate was higher, retrograde CTO PCI was associated with acceptable
procedural success rate and similar short and long-term adverse events compared with
antegrade CTO PCI.
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Background:Whether successful PCI of a coronary CTO is associated with improved
survival is the subject of debate. Using a large prospective database of patients treated
for CTO, we sought to compare long-term outcome of patients on the basis of success/
failure of the index PCI procedure.
Methods: Between 2004 and 2012, a total of 1,343 consecutive patients underwent
PCI for CTO in our centre (14 operators). We compared major adverse cardiac events
(MACE) including cardiac death, target vessel revascularisation (TVR), and
myocardial infarction (MI) in patients with successful versus failed PCI at a median
follow up of 4.1 years (IQR: 2.4-6.5 years). Procedural success was deﬁned as
achievement of residual stenosis <50% with TIMI-3 ﬂow in the target vessel.
Results: Successful treatment of CTO by PCI was achieved in 1000 (74%) patients.
These patients were younger (6311 vs. 6511 respectively p¼0,02), had lower rates
of hypertension (56.1% vs. 66.8% p<0,01), previous MI (19.5 % vs. 29.2% p<0,01)
and were more frequently treated for left anterior descending artery CTO (33.2 vs.
23.0%, p<0.01) than those in whom PCI success was not achieved. However, left
ventricular ejection fraction and diabetes mellitus were similar between groups. PCI
success was associated with signiﬁcantly lower MACE among patients with
successful PCI (16.7 vs. 22.2%, p¼ 0.0235) driven mainly by lower rate of cardiac
death at follow up (4.2 vs. 11%, p<0.0001). Independent predictors of lower cardiac
death by multivariate analysis were: successful PCI (HR: 0,42, 95% CI: 0.27-0.67,
p < 0.01), absence of previous MI (HR: 1.68, 95% CI: 1.03-2.74, p ¼0.04) and
younger age (HR: 1.05, 95% CI: 1.03-1.08, p < 0.01).
Conclusions: In this large cohort of patients treated by PCI for CTO, successful
revascularization was associated with improved clinical outcome at long-term follow-
up. This was driven by lower cardiac mortality rates among these patients.
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Background: To assess the procedural success rate and the long-term clinical impact
of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in
elderly patients.
Methods: A total of 1,343 consecutive patients with underwent PCI for 1,432 CTO
lesions between Jan 2004 and Jan 2012 at our center. Outcomes including procedural
success and major adverse cardiac events (MACE) and its components, cardiac death,
myocardial infarction and target vessel revascularization between patients aged 75
and patients aged <75 years were compared.
Results: A total of 253 patients (19%) were aged 75 years. Compared to patients
<75 years, elderly patient were more commonly female (20% vs. 11.8%, p<0.0001)
and presented most commonly with left anterior descending coronary artery CTO
(41.5% vs. 28.5%, p¼0.001). Procedural success rates were similar in both groups
(74.9% vs. 72.7%, p ¼ 0.48). Median follow-up was 4.1 years (IQR: 2.4-6.5 years).
MACE rates after successful versus failed PCI were 20.9% versus 29.8% in the elderly
(p ¼ 0.15) and 21.0 versus 24.1% in younger patients (p ¼ 0.12). In elderly patients,
this trend in reduction in MACE after successful PCI was driven by a signiﬁcant
reduction in cardiac mortality (Figure). There was also a signiﬁcant reduction in all-
cause mortality (21.1% vs. 35.9%, p ¼ 0.02) and no signiﬁcant differences in the rate
of MI (2.8% vs. 1.6%, p ¼ 0.597).B116 JACC Vol 62/18S1/Suppl B j October 27–NConclusions: PCI for CTO has similar success rate in the elderly (75 years) and is
associated with a signiﬁcant reduction in cardiac mortality when success is achieved.TCT-369
Long Term Clinical Outcome and Routine Angiographic Follow-up After
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Background: Routine follow-up angiogram data after successful recanalization of
chronic total coronary occlusions (CTO) with a long total stent length (SL) are
lacking. In the present study, we evaluated clinical and angiographic outcomes after
successful recanalization of CTO with implantation of a long total SL.
Methods: Routine follow-up angiogram were performed at 6 months after successful
recanalization of 113 CTO (antegrade approach in 81% and retrograde approach in
19%) with a long SL ( 20mm) in 108 consecutive patients.
Results: Mean number of stents was 3.8  1.8 and mean total SL was 76  33 mm
(range 20-174 mm). Drug-eluting stents (DES) were used in 106 lesions with siroli-
mus-eluting stents (SES) in 100. Instent total reocclusion occurred in 2 DES lesions
(1 SES and 1 DES non-SES). Restenosis rate was 18% in DES vs 71% in bare
metal stents group (p ¼ 0.004). In the 100 SES sub-group (total SL 79  33mm, range
23-174 mm and mean number of stents 3.9  1.8) restenosis rate was 18%; a younger
age and a longer total SL were found to be independent predictors of restenosis (HR
0.939, 95% CI 0.885-0.996, p ¼ 0.035 and HR 1.017, 95% CI 1.00-1.03 p ¼ 0.045,
respectively); restenosis type was diffuse in only 11% and 89% were successfully
treated by repeat percutaneous coronary intervention. During a median follow-up of 2
years (interquartile range: 1 to 4.3 years), major cardiac events other than those
angiographically driven at routine follow-up angiogram occurred in 3 patients (cardiac
surgery at 7, 8 and 9 months, respectively).
Conclusions: Angiographic restenosis rate remains acceptable in patients with complex
CTO successfully treated by a long total length ofDES and restenosis can be successfully
treated by repeat percutaneous coronary intervention in the vast majorty of cases.
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Background: Chronic Total Occlusions (CTOs) are commonly encountered in
patients (PTs) with Acute Coronary Syndromes (ACS). It has been reported that the
presence of a CTO is associated with increased mortality in PTs presenting with ST
elevation Myocardial Infarctions (STEMI). It is less clear if this same association is
true for PTs presenting with non-STE ACS (NSTEACS).
Methods: The Minneapolis Heart Institute has developed standard treatment protocols
for STEMI (Level 1, L1) and NSTEACS (Level 2, L2) PTs. From 2007-2011, 2062
sequential STEMI PTs and from 2009-2012, 827 sequential NSTEACS PTs who
underwent angiography were evaluated for the presence of at least one CTO in a major
coronary vessel. In-hospital, 30 day, and 1 year mortality were compared between PTs
who did and did not have a CTO.
Results: See table below:ovember 1, 2013 j TCT Abstracts/POSTER/Chronic Total Occlusions
Level 1 STEMI PTs w/angiogram, N=2062
Death w/CTO N¼297 w/o CTO N¼1765 p-value
In-Hospital Death, N (%) 39 (13.1) 63 (3.6) <0.0001
Death in 30 days, N (%) 45 (15.2) 75 (4.3) <0.0001
Death in 1 year, N (%) 65 (21.9) 133 (7.5) <0.0001
Level 2 NSTEACS PTs w/angiogram, N=827
Death w/CTO N¼203 w/o CTO N¼624 p-value
In-Hospital Death, N (%) 11 (5.4) 10 (1.6) 0.0027
Death in 30 days, N (%) 14 (6.9) 13 (2.1) 0.0008
Death in 1 year, N (%)* 11 (9.5) 25 (6.4) 0.2647
*N¼504 for 1 year (excluding 2012)
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SConclusions: Our data demonstrates that PTs with STEMI and a CTO have higher in-
hospital, 30 day, and one year mortalities than STEMI PTs without a CTO. PTs with
NSTEACS and a CTO have higher in-hospital and 30 day mortality than NSTEACS
PTs without a CTO, and there is a non-signiﬁcant trend towards increased one year
mortality for PTs with a CTO. Strategies to reduce this increased mortality are needed.
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Background: Cardiac arrest (CA) is often the result of both acute and chronic
coronary artery disease (CAD) particularly when it is caused by ventricular tachy-
cardia or ﬁbrillation (VT/VF). Therapeutic hypothermia has been shown to decrease
mortality and after resuscitated CA (rCA). It has been demonstrated that a chronic
total occlusion (CTO) in the non-infarct artery in patients (Pts) with ST segment
elevation myocardial infarction (STEMI) is associated with increased mortality.
The incidence and effect of CTOs in Pts with rCA has not been well described.
Further the incidence and effect of CTOs in rCA Pts as the result of STEMI is
unknown.
Methods: The Minneapolis Heart Institute has developed formalized protocols for both
STEMI (Level One, L1) and cardiac arrest and sequential therapeutic hypothermia (Cool-
It). From 2006-May 2012, 164 sequential Pts who had been enrolled in the Cool-It
program who presented with VT/VF and underwent angiography were evaluated for the
presence of at least one CTO in a major coronary vessel. From 2006-May 2012, 121 PTs
who had been enrolled in the Cool-It program and underwent angiography but also
suffered from STEMI were also evaluated for CTOs. In-hospital, 30 day, and 1 year
mortality were compared between Pts who did and did not have CTO. STEMI Pts who
presented with rCAwere compared to STEMI Pts without rCA for the presence of a CTO.
Results: See table below:Cool-It Pts w/angiogram and VT/VF, N=164
Death w/CTO N¼37 w/o CTO N¼127 p-value
In-Hospital Death, N (%) 15 (40.5) 37 (29.1) 0.1895
Death in 30 days, N (%) 16 (43.2) 40 (31.5) 0.1848
Death in 1 year, N (%) 17 (46.0) 43 (33.9) 0.1792
Cool-It Pts w/angiogram and STEMI, N¼121
Death w/CTO N¼30 w/o CTO N¼91 p-value
In-Hospital Death, N (%) 16 (53.3) 33 (36.3) 0.0986
Death in 30 days, N (%) 15 (50) 35 (38.5) 0.2657
Death in 1 year, N (%) 17 (56.7) 37 (40.7) 0.1261
STEMI Pts from 2007-2011, N=2062
w/rCA w/o rCA p-value
w/CTO, N (% for column) 22 (24.7) 275 (13.9) 0.0046
w/o CTO, N (% for column) 67 (75.3) 1698 (86.1)Conclusions: These data demonstrate that rCA Pts presenting with VT/VF and who
have a CTO appear to have similar mortality compared to those without a CTO. Pts
with and without a CTO who presented with rCA and STEMI have similar mortality
although there is a trend in favor of those without a CTO. STEMI Pts with rCA have
a higher incidence of a CTO than do STEMI Pts without rCA. Further efforts to
understand, treat, and avoid CA in Pts with a CTO are warranted.JACC Vol 62/18S1/Suppl B j October 27–November 1, 2013 j TCT AbTCT-372
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Background: Limiteddata exists onpatientswhohaveundergonedrug eluting stent (DES)
implantation of long chronic total occlusive (CTO) lesion in native coronary arteries.
Methods:Wedeﬁned longcontinuousstent implantation (stent length> or¼ 50mm)as"full
metal jacket" (FMJ). FromApril 2007 toMarch 2013, 344 consecutive patients (361 lesions)
who underwent FMJ using any DESs for de novo lesion were enrolled. Subjects were clas-
siﬁed into twogroups: thepatientswithCTOlesion (CTOgroup,113patients, 114 lesions) and
without CTO lesion (non-CTO group, 239 patients, 247 lesions). The two groups were
compared for mean 2419 months clinical outcomes. Endpoints were freedom from target
lesion revascularization (TLR) and major adverse cardiovascular events (MACE) deﬁned as
composite of TLR, myocardial infarction and all cause death at 5 years after percutaneous
coronary interventionprocedure.Thiswas a single center non-randomized retrospective study.
Results: CTOgroupwas younger than non-CTOgroup (66.00.9 vs. 70.00.6, p<0.05).
The percentage of male gender and hyperlipidemia were higher in CTO group than non-
CTO group (84.2% vs. 69.6%, p<0.05 and 58.8% vs. 47.0%, p<0.05, respectively). There
were no signiﬁcant differences between both study arms in percentages of diabetes mellitus
(43.0% vs. 48.6%, p¼0.32), hypertension (71.9% vs. 75.2%, p¼0.51), hemodialysis (2.6%
vs. 5.3%, p¼0.26) and current smoker (19.3% vs. 17.1%). Target vessel wasmore often the
right coronary artery in CTO group than non-CTO group (71.1% vs. 33.2%, p<0.05). The
mean total length of implanted stents was longer in CTO group than non-CTO group
(72.81.4mmvs. 60.90.9mm,p<0.05). Intravascular ultrasoundwas used in 70.0% and
follow up rate of angiographywas 75.9%. Regarding the long-term clinical outcomes, there
were no signiﬁcant differences in the rate of freedom from TLR (60.510.5% vs.
76.94.7%, Log rank p¼0.48) andMACE (53.89.9%vs. 67.24.8%,Log rank p¼0.88)
at 5 years estimated using the Kaplan-Meier methods compared to non-CTO group.
Conclusions: The strategy of FMJ using DES was acceptable for CTO lesions.
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Decreasing R-wave Amplitude During Percutaneous Coronary Intervention for
Chronic Total Occlusion in the Retrograde Approach
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Background: The use of retrograde approach for recanalization of chronic total occlusion
(CTO) has been established with improved success rates. During the procedure of percuta-
neous coronary intervention (PCI) for CTO lesions in the retrograde approach, electrocar-
diographic R-wave amplitudes often decrease in many leads. Because the differential
diagnoses of low voltages on electrocardiogram (ECG) include pericardial effusion, the
presence of these changes should increase the index of suspicion for a signiﬁcant pericardial
effusiondue to coronaryperforation andprompt further evaluation suchas echocardiography.
Methods: We analyzed the recent 30 patients (group-R, age 6512) who underwent
successful PCI for CTO lesions in the retrograde approach and the recent 30
patients (group-E, age 6010) who underwent treatment for pericardial effusion
during catheter intervention. Group-E was divided into 2 groups according to whether
requiring drainage of effusion [group-E/D(+) ,n¼15] or not [group E/D(-), n¼15].
Pre-ECG was deﬁned as the ECG just before the catheter intervention. Post-ECG was
deﬁned as the ECG just before the procedure of drainage for Group-E/D(+) and the
ECG immediately after catheter intervention for other groups.
Results: In comparison of pre-ECG and post-ECG, the leads in which R-wave
amplitude signiﬁcantly decreased were I, II, aVL, V1,V4, V5, and V6 in group-R; I,
II, aVL,V4, V5, and V6 in group-E/D(+); but only aVL in group-E/D(-). Heart rate
(HR) signiﬁcantly increased in group-E /D(+) (6412 to 8318, p¼0.0034) between
the 2 ECGs, but not in group-R and group-E/D(-). Comparing group-R and group-E/
D(+), the rate of R-wave amplitude between the 2 ECGs [(R-wave amplitude in post-
ECG)/(R-wave amplitude in pre-ECG)] was similar in all leads. But the rate of HR
between the 2 ECGs [(HR in post-ECG) / (HR in pre-ECG)] was higher in group-E/
D(+) (0.960.34 vs 1.320.29, p¼0.0024). Comparing group-R and group-E/D(-),
the rate of HR between the 2 ECGs was similar. But the rate of R-wave amplitudes
between the 2 ECGs of group-R was signiﬁcantly lower in leads I(0.660.25 vs
0.990.58, p¼0.0074), II(0.880.33 vs 1.200.41, p¼0.014), V1(0.720.29 vs
1.110.55, p¼0.0019), and V5(0.670.31 vs 0.950.30, p¼0.0042).
Conclusions: During the procedure of PCI for CTO lesions in the retrograde approach,
ECG shows decreasing R-wave amplitudes similarly with the case of pericardial effusion
requiring drainage during catheter intervention. However, by taking HR into account,
decreasingR-wave amplitude during PCI for CTO lesions in the retrograde approach could
bediscriminated fromECGchangesdue topericardial effusionduring catheter intervention.
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Results of the ALSTER CTO-OCT registry: Delayed DES endothelialization
after subintimal recanalization of chronic of total occlusion: Observation by
optical coherence tomography
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